PBHLTH 150A — Unit 1 Gordis Readings

0.0(0)
Studied by 4 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/174

encourage image

There's no tags or description

Looks like no tags are added yet.

175 Terms

1
New cards

rates

express the frequency of a given event (disease case or death) in relation to a unit of time

2
New cards

proportions

tells us what fraction of the population has a disease of interest; a subset divided by whole

3
New cards

incidence

number of NEW cases of disease; identified in people who newly develop the disease and have not had the disease previously.

4
New cards

is incidence a measure of risk?

YES, it is a measure of risk since it is a measure of events (i.e. transition from non-disease to diseased)

<p>YES, it is a measure of risk since it is a measure of events (i.e. transition from non-disease to diseased)</p>
5
New cards

what are the two types of denominators for incidence measures?

1. people at risk who are observed throughout a defined time period

2. units of time when each person is observed (person time)

6
New cards

what is the denominator of incidence?

the denominator represents the people who are AT RISK for the disease. any individual who is included in the denominator must have the potential to become a part of the group

e.g. when calculating the incidence of uterine cancer, the denominator should only include females with no history of hysterectomy, since males and females with hysterectomies would never get this cancer.

7
New cards

cumulative incidence

the frequency of NEW cases of a disease that occur during a specific period of TIME in a population AT RISK for developing the disease.

<p>the frequency of NEW cases of a disease that occur during a specific period of TIME in a population AT RISK for developing the disease.</p>
8
New cards

incidence rate

the rate in which individuals are observed for different lengths of time. the denominator is person time

<p>the rate in which individuals are observed for different lengths of time. the denominator is person time</p>
9
New cards

person time

the denominator of incidence rate. it consists of the sum of the units of time that each individual was at risk and was observed.

often expressed in person years (py)

<p>the denominator of incidence rate. it consists of the sum of the units of time that each individual was at risk and was observed.</p><p>often expressed in person years (py)</p>
10
New cards

explain how person years (py) works.

one person who is observed for 1 year = 1 py.

one person who is observed for 5 years = 5 py.

5 at-risk people observed for 1 year = 5 py

11
New cards

if people at risk are observed for different periods of times, the incidence rate is:

see image.

<p>see image.</p>
12
New cards

step 1: screening for prevalent cases at baseline

first, identify a population.

determine who has a disease and who does not. those who have the disease are considered "prevalent cases"

follow up with those who did not have the disease at baseline

13
New cards

step 2: follow up and re-screening at 1 year to identify cases that developed during that year

once followed up with those who did not have the disease at baseline, wait 1 year until rescreening.

follow up with the population at 1 year there will be a portion of the population who develop the disease -- these are new cases.

14
New cards

prevalence proportion

the number of affected people present in a population at a specific time divided by the number of people in the population at the time

<p>the number of affected people present in a population at a specific time divided by the number of people in the population at the time</p>
15
New cards

prevalence

a snapshot or a slice through the population at a point in time in which we determine who has a disease and who does not.

when the disease was developed is not determined nor the duration of the disease.

16
New cards

incidence vs prevalence

Incidence is the rate of occurrence in a specified group of people. usually studied in longitudinal method.

prevalence is determined by counting the number of individuals who currently have it. usually done by cross-sectional.

<p>Incidence is the rate of occurrence in a specified group of people. usually studied in longitudinal method.</p><p>prevalence is determined by counting the number of individuals who currently have it. usually done by cross-sectional.</p>
17
New cards

what are the two types of prevalence?

point prevalence

period prevalence

18
New cards

point prevalence

prevalence of a disease at a certain point in time; often referred to as just prevalence

takes time to gather data

19
New cards

period prevalence

how many people have had the disease at any point during a certain time period?

time period could be anything, 2 months, 3 years, etc.

20
New cards

give examples of the two types of prevalence and cumulative incidence, regarding asthma.

Point prevalence: do you currently have asthma?

period prevalence: have you had asthma during the last [x] years?

cumulative incidence: have you ever had asthma?

21
New cards

what is the relationship between incidence and prevalence? think of the flask drawings.

to add or increase prevalence: through incidence; adding new cases

to lower prevalence: can occur through either death or cure

therefore: new cases (incidence) increases prevalence whereas deaths/cures decreases prevalence

<p>to add or increase prevalence: through incidence; adding new cases</p><p>to lower prevalence: can occur through either death or cure</p><p>therefore: new cases (incidence) increases prevalence whereas deaths/cures decreases prevalence</p>
22
New cards

if prevalence is not a risk measure, why should we estimate prevalence?

prevalence is an important and useful measure of the burden of disease in a community to inform resource allocation by decision-makers. (e.g. how many clinics are needed, services, etc.)

23
New cards

name some possible sources of morbidity statistics

1. disease reporting

2. data accumulated as a by-product of insurance and medical plans

3. hospitals and clinics

4. absenteeism records (school, work)

5. pre-employment physical exams and periodic exams

6. morbidity surveys on population samples (e.g. NHS, NCS)

24
New cards

what are some problems that can arise with NUMERATORS, specifically when discussing incidence and prevalence measurements?

1. defining who has the disease. some diseases are difficult to diagnose

2. who should be included in the numerator; how do we find the cases? can be done with readily available data, studies, etc. but can be limited/inaccurate.

25
New cards

what are some problems that can arise with DENOMINATORS, specifically when discussing incidence and prevalence measurements?

1. undercounting populations

2. using either corrected or uncorrected rates

26
New cards

mortality rate

also called annual death rate. it is the total number of deaths from all causes in one year divided by the number of people in the population at midyear

because population changes over time, the number of people at midyear is generally used as an approximation of the average population of the year.

REMEMBER: anyone in the group represented in the denominator must have the potential to enter the denominator

mortality rate can be adjusted if interested in certain age groups; this change must be reflected in both numerator and denominator

<p>also called annual death rate. it is the total number of deaths from all causes in one year divided by the number of people in the population at midyear</p><p>because population changes over time, the number of people at midyear is generally used as an approximation of the average population of the year.</p><p>REMEMBER: anyone in the group represented in the denominator must have the potential to enter the denominator</p><p>mortality rate can be adjusted if interested in certain age groups; this change must be reflected in both numerator and denominator</p>
27
New cards

what is specific rate?

specific for a certain group.

examples include: mortality rates for children under age 10 (age-specific mortality rate), rates for specific diagnoses (disease specific rate)

28
New cards

case-fatality

what percentage of people who have a certain disease die within a certain time after the disease was diagnosed?

measure of the severity or fatality of disease

this is a PROPORTION

29
New cards

mortality rate vs case-fatality

in mortality rate: denominator represents the entire population at risk of dying from the disease. this includes both who have the disease and who do not have it.

in case-fatality: denominator is limited by those who already have the disease. determines the proportion of people who died from people who already had the disease.

30
New cards

proportionate mortality

the proportion of deaths that are attributable to a specific cause. e.g. what proportion was caused by cardiovascular disease?

31
New cards

years of potential life lost (YPLL)

measure of premature mortality (early death)

YPLL recognizes that death occurring in a person at a younger age involves a greater loss of future productive years than death occurring at an older age

32
New cards

how to calculate YPLL

1. for each cause, each deceased person's age at death is subtracted from a predetermined (or average) age at death (e.g. 75 is the average in the U.S. dying at 50 is 75-50 = 25)

2. the YPLL for each individual are then added together to yield the total YPLL for the specific cause of death

<p>1. for each cause, each deceased person's age at death is subtracted from a predetermined (or average) age at death (e.g. 75 is the average in the U.S. dying at 50 is 75-50 = 25)</p><p>2. the YPLL for each individual are then added together to yield the total YPLL for the specific cause of death</p>
33
New cards

why is YPLL important? list three reasons.

1. establishes research and resource priorities

2. surveillance of temporal trends in premature death

3. evaluating the effectiveness of program interventions

34
New cards

when is mortality rate a good reflection of the incidence rate?

1. when case-fatality is high

2. when the duration of the disease (survival) is short

in these conditions, mortality is a good measure of incidence, thus a measure of risk of disease

35
New cards

underlying cause of death

The disease or injury which initiated the train of morbid events leading directly or indirectly to death or the circumstances of the accident or violence which produced the final injury.

36
New cards

what are two main problems with mortality data?

1. Coding categories and regulations for the International Classification of Diseases change from one revision to another. Therefore, any study that spans more than one revision must examine the possibility that observed changes could be entirely or in part of the changes in the ICD.

2. changes in the definition of the disease can have an effect of the number of cases that are reported.

37
New cards

crude mortality

deaths from all causes/population at risk for death. also known as unadjusted mortality

<p>deaths from all causes/population at risk for death. also known as unadjusted mortality</p>
38
New cards

direct age adjustment

a standard population is used in order to eliminate the effects of any differences in age between two or more populations being compared

<p>a standard population is used in order to eliminate the effects of any differences in age between two or more populations being compared</p>
39
New cards

age adjusted rates

Epidemiological data that have been manipulated, using standard statistical techniques, to eliminate any effects that arise because some populations include more older or younger persons than do others.

<p>Epidemiological data that have been manipulated, using standard statistical techniques, to eliminate any effects that arise because some populations include more older or younger persons than do others.</p>
40
New cards

what are two things one should keep in mind when analyzing mortality data in regards to age adjusted rates?

1. when examining and analyzing comparative mortality data, one should carefully examine the age specific rates for any changes or differences

2. age adjusted rates are hypothetical because they involve applying actual age specific rates to a hypothetical standard population

41
New cards

indirect age adjustment

used when numbers of death for each age-specific stratum are not available, and to study mortality in occupationally exposed population

42
New cards

standardized mortality ratio (SMR)

the ratio of the observed number of deaths (or cases) in a study population to the expected number of deaths in that same population

<p>the ratio of the observed number of deaths (or cases) in a study population to the expected number of deaths in that same population</p>
43
New cards

what are some possible explanations of trends or differences in mortality?

- change in diagnostic modalities or management strategies

- change in survivorship without incidence change

- change in incidence

- change in age composition of the population(s)

- a combination of one or more above factors

44
New cards

what are two other measures of the impact of disease?

quality of life and projecting the future burden of disease

45
New cards

why should quality of life also be taken into account when prioritizing health care resources?

many diseases are chronic and non life threatening and may be associated with many years of disability, having physical and mental health consequences

46
New cards

why may measuring quality of life and developing indices that are useful to obtain comparative data in different patients and populations remain challenging?

patients may place different weights on different quality of life measures depending on their occupations and other activities, personalities, cultural backgrounds, education, and more.

47
New cards

disability adjusted life year (DALY)

the number of years of life lost to premature death and years lived with a disability of specified severity and duration

a DALY is 1 lost year of healthy life.

48
New cards

bimodal curve

a distribution where there are two peaks

<p>a distribution where there are two peaks</p>
49
New cards

unimodal curve

a distribution where there is one peak

<p>a distribution where there is one peak</p>
50
New cards

what is test validity? what are the two components of test validity?

a test's ability to correctly distinguish between who has a disease and who does not.

there are two components: sensitivity and specificity

51
New cards

sensitivity definition and formula

definition: the ability of a test to correctly identify those who HAVE the disease

formula: (True Positive)/(True Positive + False Negative)

<p>definition: the ability of a test to correctly identify those who HAVE the disease</p><p>formula: (True Positive)/(True Positive + False Negative)</p>
52
New cards

specificity definition and formula

definition: the ability of the test to correctly identify those who DO NOT HAVE the disease

formula: (True Negative)/(True Negative + False Positive)

<p>definition: the ability of the test to correctly identify those who DO NOT HAVE the disease</p><p>formula: (True Negative)/(True Negative + False Positive)</p>
53
New cards

true positive

people WITH a disease who are correctly called "positive" by a test

54
New cards

true negative

people WITHOUT a disease who are correctly called "negative" by a test

55
New cards

false positive

people WITHOUT a disease who are correctly called "positive" by a test

56
New cards

false negative

people WITH a disease who are correctly called "negative" by a test

57
New cards

why can false positives be so problematic?

all people who screen positive are brought back for more sophisticated and more expensive tests, or even go through tests that are invasive. this is both a burden on the healthcare system and can be expensive.

furthermore, these people are then filled with anxiety and worry.

58
New cards

why can false negatives be so problematic?

if a person has a serious disease and is only curable in its early stages, a false negative can lead to a virtual death sentence.

59
New cards

what's the relationship between sensitivity and specificity when trying to determine cutoff levels? (i.e. what happens to one if the other is lowered?)

there is a trade off between sensitivity and specificity.

if we increase the sensitivity by lowering the cutoff level, we decrease specificity.

if we increase the specificity by raising the cutoff level, we decrease sensitivity.

60
New cards

how can we decide whether we want a high or low cutoff level for screening?

it depends on the importance we attach to false positives and false negatives.

false positives are associated with costs (both emotional and financial) as well as with the difficulty of "delabeling" a person who tests positive and is later found to not have the disease. finally, it poses a burden to the healthcare system as these individuals must be brought it for additional testing.

false negatives can lead to a serious disease being missed at an early treatable stage.

61
New cards

sequential screening

a less invasive/comfortable/expensive test is performed first → further testing for those who tested positive on the first test, which is usually expensive/invasive/uncomfortable.

the second test may have greater sensitivity and specificity.

62
New cards

sequential testing formula

use the values from the A cube in table 1 to fill out the values in the A and C cube in table 2.

use the values from the B cube in table 1 to fill out the values in the B and D cube in table 2

<p>use the values from the A cube in table 1 to fill out the values in the A and C cube in table 2.</p><p>use the values from the B cube in table 1 to fill out the values in the B and D cube in table 2</p>
63
New cards

simultaneous testing

all individuals being screened are given both tests at the same visit

net gain in sensitivity and net loss in specificity

64
New cards

net sensitivity

in simultaneous testing, must be POSITIVE in EITHER test to be considered a positive.

formula: (positives in only Test A + Positives from both tests + Positives in only Test B) / (People with the Disease)

<p>in simultaneous testing, must be POSITIVE in EITHER test to be considered a positive.</p><p>formula: (positives in only Test A + Positives from both tests + Positives in only Test B) / (People with the Disease)</p>
65
New cards

net specificity

in simultaneous testing, must be NEGATIVE in ALL tests to be considered negative (numerator).

(Negatives in both tests) / (People without the Disease)

<p>in simultaneous testing, must be NEGATIVE in ALL tests to be considered negative (numerator).</p><p>(Negatives in both tests) / (People without the Disease)</p>
66
New cards

when two ______ tests are used and those who test positive by the first test and brought in for the second test, there is a net loss in ______ but a net gain in ______.

sequential; sensitivity; sensitivity.

67
New cards

when two ______ tests are used, there is a net gain in ________ but a net loss in ______.

simultaneous; sensitivity; specificity.

68
New cards

when should you use sequential testing vs simultaneous testing?

this decision depends on the objectives of testing

this includes whether testing is being done for screening or diagnostic purposes, and on practical considerations related to the setting in which the testing is being done, including the length of hospital stay, costs, and degree of invasiveness of each tests, as well as the extent of third-party insurance coverage.

69
New cards

positive predictive value (PPV) definition and formula

a proportion that helps clinicians answer the question, "what proportion of patients who test positive actually HAVE the disease?"

(True Positives) / (True Positives + False Positives)

<p>a proportion that helps clinicians answer the question, "what proportion of patients who test positive actually HAVE the disease?"</p><p>(True Positives) / (True Positives + False Positives)</p>
70
New cards

negative predictive value (NPV) definition and formula

a proportion that helps clinicians answer the question, "if the test result is negative, what is the probability that this patient DOES NOT have the disease?"

(True Negatives) / (True Negatives + False Negatives)

<p>a proportion that helps clinicians answer the question, "if the test result is negative, what is the probability that this patient DOES NOT have the disease?"</p><p>(True Negatives) / (True Negatives + False Negatives)</p>
71
New cards

the higher the ______, the higher the PPV.

prevalence

72
New cards

why should we be concerned about the relationship between predictive value and disease prevalence?

a screening program is most productive and more cost effective if it's directed to a high-risk target population.

73
New cards

is it possible for the same test to have very different predictive value when administered to a high risk (aka high prevalence) population or to a low-risk (low prevalence) poplation

yes.

74
New cards

a change in ______ has a greater effect on predictive value than a comparable change in _____.

specificity; sensitivity

75
New cards

intrasubject variation

variation within individual subjects

e.g. changes in blood pressure readings over a 24-hr interval. changes can be caused by food ate, exercise done, etc.

<p>variation within individual subjects</p><p>e.g. changes in blood pressure readings over a 24-hr interval. changes can be caused by food ate, exercise done, etc.</p>
76
New cards

intraobserver variation

variation occurring between two or more readings of the same test made by the SAME OBSERVER.

77
New cards

interobserver variation

variation between TWO EXAMINERS who do not give the same test results

78
New cards

what percent agreement and why may we disregard cell D?

The proportion of all observations where two (or more) readers agree.

why may disregard cell D because there is likely considerable agreement between the two observers about those negative subjects. this value may be high due to the large number of of clearly negative findings (cell D). thus, the high value may CONCEAL SIGNIFICANT DISAGREEMENT between observers in identifying subjects who are considered positive by at least one observer.

<p>The proportion of all observations where two (or more) readers agree.</p><p>why may disregard cell D because there is likely considerable agreement between the two observers about those negative subjects. this value may be high due to the large number of of clearly negative findings (cell D). thus, the high value may CONCEAL SIGNIFICANT DISAGREEMENT between observers in identifying subjects who are considered positive by at least one observer.</p>
79
New cards

Kappa Statistic definition

A measure of the degree of nonrandom agreement between observers of the same categorical variable. in other words, the best method for assessing the level of agreement among several observers.

we want to answer the question, "To what extent do their readings agree beyond what we would expect by chance alone?"

80
New cards

kappa statistic

see image

<p>see image</p>
81
New cards

what are the two things you need to calculate the Kappa statistic?

• percent agreement observed

• percent agreement by chance

82
New cards

a kappa greater than _____ represents excellent agreement beyond chance. a kappa below _____ represents poor agreement and a kappa of _____ to _____ represents intermediate to good agreement.

0.75; 0.40; 0.40 to 0.75

83
New cards

when the reliability or repeatability of a test is poor, the ____ of the test for a given individual also may be poor.

validity.

84
New cards

early detection of disease

diagnosing a disease at an earlier stage than would usually occur in standard clinical practice

the disease is being detected at a pre-symptomatic stage, at which the patient has no clinical complaint (no symptoms/signs) and thus, no reason to seek for medical care for the condition

85
New cards

how do we assess the effectiveness of screening programs using outcome measures? (i.e., what are some of the possible outcome measures that might be used?)

1. reduction of mortality in the population screened

2. reduction of case mortality in screened individuals

3. increase in percent of cases detected in earlier stages

4. reduction in complications

5. prevention of OR reduction in recurrences or metastases

6. improvement of quality of life in screened individuals

86
New cards

natural history of disease

course or progression of a disease process from onset to resolution

to study image, refer to pg 1027 in Gordis

87
New cards

into what two phases can the period during which a disease is present be divided?

preclinical phase and clinical phase

<p>preclinical phase and clinical phase</p>
88
New cards

preclinical phase

the period from biologic onset of the disease to the development of signs and symptoms

comes BEFORE the clinical phase; a phase in which disease presence can be divided into

<p>the period from biologic onset of the disease to the development of signs and symptoms</p><p>comes BEFORE the clinical phase; a phase in which disease presence can be divided into</p>
89
New cards

clinical phase

the period from the time when signs and symptoms develop to an ultimate outcome such as possible cure, control of the disease, or death

comes AFTER the preclinical phase

<p>the period from the time when signs and symptoms develop to an ultimate outcome such as possible cure, control of the disease, or death</p><p>comes AFTER the preclinical phase</p>
90
New cards

primary prevention

an intervention BEFORE the disease is developed. this is BEFORE the preclinical phase

e.g. immunization and prevention of smoking initiation

<p>an intervention BEFORE the disease is developed. this is BEFORE the preclinical phase</p><p>e.g. immunization and prevention of smoking initiation</p>
91
New cards

secondary prevention

detecting disease at an earlier stage than usual. takes place DURING the preclinical phase

e.g. screening

<p>detecting disease at an earlier stage than usual. takes place DURING the preclinical phase</p><p>e.g. screening</p>
92
New cards

tertiary prevention

treating clinically ill individuals to prevent complications of the illness, including death of the patient

e.g. stroke rehabilitation

<p>treating clinically ill individuals to prevent complications of the illness, including death of the patient</p><p>e.g. stroke rehabilitation</p>
93
New cards

detectable preclinical phase

point during preclinical phase before symptoms develop but disease can be detected using tests

<p>point during preclinical phase before symptoms develop but disease can be detected using tests</p>
94
New cards

lead time

interval by which the time of diagnosis is advanced by screening and early detection compared to usual time of diagnosis

<p>interval by which the time of diagnosis is advanced by screening and early detection compared to usual time of diagnosis</p>
95
New cards

critical point

a point in natural history before which treatment is more effective and/or less difficult to administer

there can me multiple critical points, which suggests that the earlier the diagnosis, the better the prognosis.

<p>a point in natural history before which treatment is more effective and/or less difficult to administer</p><p>there can me multiple critical points, which suggests that the earlier the diagnosis, the better the prognosis.</p>
96
New cards

choose the correct words: if we (can/cannot) envision one or more critical points in the natural history of disease, then there is clearly (a/no) rationale for screening and early detection

cannot; no

97
New cards

what are the two assumptions we must hold if we want to see potential benefit from screening and early detection?

1. all or most clinical cases of a disease first go through a detectable preclinical phase

2. in the absence of intervention, all or most cases in a pre-clinical phase progress to a clinical phase

98
New cards

case reports and case series

describes the experience of a single patient or group of patients with similar diagnosis; documenting a comprehensive and detailed description of the case(s) under observation.

this allows other physicians to identify and potentially report similar cases from their practice.

<p>describes the experience of a single patient or group of patients with similar diagnosis; documenting a comprehensive and detailed description of the case(s) under observation.</p><p>this allows other physicians to identify and potentially report similar cases from their practice.</p>
99
New cards

what are the advantages of case reports and case series?

• they are key hypothesis-generating tools, especially when they are simple, inexpensive, and easy to conduct

100
New cards

what are the disadvantages of case reports and case series?

• the lack of comparison group

• external validity (generalizability) is limited, given the possibly biased selection of cases